Sunday, February 12, 2017

Toray & Mitsui Sugar Form JV for Biochemicals Production from Bagasse

Toray Industries has announced that it has decided to establish a joint venture company with Mitsui Sugar for seeking business opportunities for manufacturing system of cellulosic sugar, a raw material used for producing various biochemical products, from the surplus bagasse generated at sugar mills.


Chemical Products Made from Inedible Biomass:

The technological demonstration is part of the research and technological development of bioprocess using membranes that combines Toray's water treatment membrane and bio technologies. Bioprocess using membranes is a technology that would enable the production of a high quality, low cost cellulosic sugar from inedible biomass while saving 50% energy in manufacturing by using water treatment membranes in the saccharificationand refining processes, and contributes to the realization of materials and chemical products made from inedible biomass.







Energy-Saving Cellulosic Sugar Production System:

Further, Toray and Mitsui Sugar will carry out the Demonstration Project for an Energy-Saving Cellulosic Sugar Production System using Bagasse in the Kingdom of Thailand under the International Energy Conservation Technology and System Demonstration Project of New Energy and Industrial Technology Development Organization (NEDO) and the project is aimed at examining the possibilities of commercialization of the cellulosic sugar production system. Thailand is one of the foremost producers of sugarcane in the world and is the largest exporter of sugar in Asia. It has been promoting biomass-based businesses as well as research and technology development and is suitable for pursuing the demonstration project. 



High Quality Cellulosic Sugar:

The demonstration plant of this project will have a capacity to handle 15 tons of bagasse per day (dry weight) and will manufacture about 4.2 tons of cellulosic sugar after going through the processes of pretreatment, enzymatic saccharification, and membrane separation. The pilot plant will employ concentration technology that uses Toray's water treatment membranes to produce high quality cellulosic sugar while conserving energy. Cellulosic sugar can be used as a raw material for producing various biochemical products such as ethanol, lactic acid and succinic acid, and this would enable the creation of a new supply chain from surplus bagasse to biochemical products

Further, in addition to cellulosic sugar, the plant will manufacture polyphenol and oligosaccharide, which can be made into livestock feed, using the same raw material and process to raise the economic benefit of using bagasse and the company will pursue commercialization through the demonstration project. 

Toray places environment as the linchpin of its business strategy so as to contribute to the realization of a sustainable low-carbon society, and under this management policy, the company has established itself as a pioneering comprehensive chemical manufacturer in Japan to promote LCM environment management based on the LCA concept. As part of its endeavor, Toray will actively pursue open innovation between different industries related to bioconversion technology using membranes and drive forward the development of supply chain and provisioning of solutions.



Source: Toray

Friday, February 10, 2017

*Plastics Modification: Conference & Toll-Compounding Center*

Delight your customers by “Improving Plastic Formulations”. Join us andnetwork with the entire value-chain from suppliers to BRAND-OWNERS such asJohnson & Johnson at our upcoming conference “*Plastics Modification:Industrial-to-Medical Products*”, Atlanta, GA, March 7-9, 2017

Below are the 5-Sessions at this conference:

*1.* *Advances in SURFACE Optics *&* Aesthetics*

*2.* *Latest on LIGHT-WEIGHTING Technologies*

*3.* *Evolving Trends *&* Update on FLAMMABILITY*

*4.* *Modification of MEDICAL Plastics*

*5.* *Improving STRUCTURAL *&* BUILDING Products*


For Conference details, please CLICK on the link below;
*https://innoplastsolutions.com/plastics-modification

Tuesday, February 7, 2017

HOW CAN ANTI-BACTERIAL PLASTIC SHEET ELEMINATE MRSA IN SHORT PERIOD IN OPERATION THEATRE

RACPLA Plastic sheet which is incorporated with Silver antimicrobial technology to eliminate micro-organisms. I think it is one time investment for many years and it's cost effective as well for long term basis.



1. Racquet Plastics, Belgium (Plastic sheet makers for all Hospitals)
Website: http://www.racquet-plastics.eu/index.html
ISO 22196 / JIS Z2801 Certified ANTIMICROBIAL PLASTIC SHEET to eliminate MRSA-HOSPITAL BUG ,E-COLI,SALMONELLA and MYCOBACTERIUM TUBERCLOSIS,Algae,Fungi and others.

Combination sheets: Special sheets to be made to eliminate tuberculosis bacteria, algae, fungi, and MRSA,Ecoli, salmonella bacteria.And can be used this sheet in Operation Theater,Patient ward,ICU ,Laboratory,and corporate office.
Also this can be used in the following areas:
Wall lining in meat processing unit and poultry farms.




Wall lining animal operating theatre (horse, etc)
Wall line Quarantine tables
Wall lining Brewery
Egg incubator system,
mobile lab, stationary lab.

TB:
Combi sheets which can eliminate Mycobacterium Tuberclosis (TB)bacteria in short period.
Regarding TB there's not much what the supplier have, but if you understand the value of their Institute of Tropical Medicine, you will realize the certificate is powerful.
http://www.itg.be/itg/generalsite/Default.aspx?WPID=689&MIID=674&L=E

Attached the test certificate on Belgium's company plastic sheets for TB.

These sheets can be place on ceilings,walls and flooring for long term performance against TB and other bacteria.

A single sheet size :1000 x 1500 mm

Kindly drop me an email (rosaram211@gmail.com) for better understanding of the product and the installed projects.Now this sheets are available in India.Investors are welcome to reach me to discuss about this business for the Indian/Asian market.

Wednesday, February 1, 2017

Dear Colleagues,
This is to inform that i have been providing services to market research Analysis report for couple of market research companies/customers from Europe,North and South America and Asian market.Besides this,i help companies who wants to penetrate in the Asian and European market in all these years.Have associated with couple of companies in North and South America,Europe,India,China and other Asian countries. Corporate can approach me,in case you need of my marketing consultancy to promote your products to my customer base and bring new customers/buyers to your organization in the future.I can provide you complete service in the marketing and make sure that to meet the customers to promote your products( chemicals,all type of fibers, polymers,machinery, and end products ) to the targeted customers .You can reach me on my email to have more detailed discussion about the product /report that you want from my side.I can provide my support based on hourly/weekly/long term basis as well.

Muthuramalingam 
Gruntech Polymer Consultants 
India 
Mob+91-9884895802 
Email:muthu@gruntech.com 
rosaram211@gmail.com 
My Linkedin page: http://in.linkedin.com/pub/muthuramalingam-krishnan/8/4b4/5a4

Saturday, January 28, 2017

MYBiomass and API Join Hands for Nanocellulose Production Using Biomass

MYBiomass and API announced a Joint-Development Work (JDA) for production of nanocellulose and cellulosic sugars from oil palm empty fruit-bunches (EFBs) into material as enhancing additives in textile, paper, and automotive parts amongst others. The JDA is funded by MYBiomass and harnesses MYBiomass’ strength in oil palm biomass supply, technology adaptation, market development, and combines this with API’s technical and material development expertise. 
MYBiomass’s goal is to be a pioneer in setting up commercial biorefineries with potential participation from technology providers, off-takers and investors. This is in-line with the Malaysian Biomass Initiative (MBI) as it addresses the potential of moving up the value-chain, promotes sustainable feedstock supply, and shifts focus to higher-value downstream production.
According to MYBiomass’s CEO Ms. R. Puvaneswari, “The biomass potential is huge but remains largely untapped. As an innovative business venture, MYBiomass uses an inclusive 360° public-private business model - bringing feedstock, technology, and market players to bridge supply-chain gaps, and manage risks involved; thus developing a sustainable ecosystem for Biorefineries. We are glad to partner with an innovative and capable company like API to support the national vision of being a regional green chemicals and materials hub. MYBiomass will work closely with downstream partners for product applications and move towards the establishment of the commercial Biorefinery."

Nanocellulose Products
API’s CEO Dr. Theodora Retsina remarks, “We are excited to work with MYBiomass to develop market and prototype applications using nanocellulose made from EFBs, which can add value to many established supply chains, including those targeted in this JDA. MYBiomass brings to this partnership innovative thinking to elevate the value created from Malaysia’s natural resources and the integration with partners along the entire supply chain to consumer products. API has developed a suite of nanocellulose products including hydrophilic and hydrophobic varieties. Our Bioplus™ production process is robust, flexible, low cost and can virtually use any biomass as feedstock.
According to Dr. Kim Nelson, VP Nanocellulose Technology, “We are very excited to expand our biorefinery technologies to Malaysia in support of the country’s vision to become a regional green chemicals and biomaterials hub. Upgrading residual biomass to next-generation, high-performance renewable materials such as nanocellulose in support of global job creation and sustainable economic growth is central to API’s mission.”
Source: API

Stora Enso to Build Production Unit for Biocomposite Granules

Stora Enso is investing EUR 12 million to build a new production line that will manufacture biocomposite granules at Hylte Mill in Sweden. Biocomposite granules enable the use of renewable wood to substitute a large portion of the fossil-based materials in products typically produced in plastics. Production is scheduled to begin during the first quarter of 2018. The annual capacity will be approximately 15 000 tons per year. The ramp-up of the new production line and a new type of manufacturing is expected to take 2–3 years.

Innovative & Sustainable Alternative


“This investment is part of Stora Enso’s transformation into a renewable materials company and demonstrates our ability to provide an innovative and more sustainable alternative to plastics. With this new biocomposite production line, we are well positioned to capture growth opportunities in climate and environmental friendly materials,” says Jari Suominen, EVP, Head of Stora Enso’s Wood Products division.

Best Use of Available Resources


At Hylte Mill, Stora Enso can make best use of the resources available: an industrial infrastructure, the local supply of raw material and a highly competent workforce. The estimated total employment impact for Hylte is 20 FTE’s.

Once finalized, the investment will increase Stora Enso’s Wood Products sales by approximately EUR 25 million and will exceed the division's profitability target, operational return on operating capital (ROOC) of 18%. The biocomposite business will belong to the Wood Products division.

Biocomposite granules are a mix of wood fibers, polymers and additives and are used as raw material for injection molding and the extrusion of products traditionally manufactured solely from plastic. The material can be used in a wide range of products from consumer goods (dish brushes, pots, etc.) to industrial applications, such as pallets or load bearing structures reinforced by glass fiber.


Source: Stora Enso

Tuesday, January 17, 2017

Health Checkup Packages for CORPORATES in INDIA



BIOLINE LABORATORY
•a chain of clinical laboratory , 
• is an ISO 9001:2008 laboratory, certified by TUV Rheinland
•NABL accredited
•dedication, commitment, ambience, technology, human resource, technical expertise, customer care, accuracy are the main pulses of Bioline laboratory
•Branches in Tamilnadu, Kerala, Karnataka and Andhra Pradesh.North India presence will be available in major cities in 2017.
Corporate Social Responsibility:
•is all about people –  patients, staff,  partners and  local community -  Corporate Social Responsibility (CSR) is important for us
•committed to CSR and Our diagnostic services benefited by lakhs of people in south India
•In many of the corporate organization we conducted camp - lot of employees got their new life from our diagnostics services
•we created the Preventive health care awareness in the society
Major Corporate Customers:
1. Enoah Isolution Pvt Ltd
2. G4S Secure solution India Pvt Ltd
3. Union Bank of India 
4. Abbott India 
5. KG Denim Limited
6. Azidus
7. Step pharma
8. FTC & many more
Why Choose us:
•We are fully compliant
•We are having clinical staff over 25 years of combined experience
•We are having the state of the art medical equipment
•We are having strong emphasis on quality control & policies
• our lab is a one stop shop literally & strong Corporate Social Responsibility
•has a strong digital presence & centers have loaded amenities
For camps,kindly contact me through my email with details.We will reach you with our quotation shortly.
Contact details:
Muthuramalingam
My Linkedin page:

Fraunhofer IWU experts present new materials for additive manufacturing at their self-printed booth

This year’s exhibits at Formnext focuse on materials particularly suited for aerospace applications but so far rarely used in LPBF (Laser Po...